Secondary Logo

December 2018 - Volume 38 - Issue 6

  • Richard I. Shader, MD
    David J. Greenblatt, MD
  • 0271-0749
  • 1533-712X
  • 6 issues / year
  • Psychiatry 21/142; Pharmacy and Pharmacology 22/261
  • 3.134

Hybrid Open Access

As all of you know, many innovations are taking place in journal publishing, especially now that we appear to be approaching a total digital age. Our publisher, Wolters Kluwer | Lippincott Williams & Wilkins, has responded to this and to a growing interest in open access (OA) and the increasing number of requirements from funding bodies and institutions for public availability of the work by implementing an article-level open access option for many of its journals. Commonly known as "Hybrid Open Option (HOA)", JCP will continue to be sold on a subscription basis, but authors may opt to make their articles freely available online immediately upon publication by paying an Article Processing Charge (APC). Any additional standard publication charges for print, such as for color images, may also apply.

Our instructions to authors is updated to facilitate this change.

Richard I. Shader, M.D.

David J. Greenblatt, M.D.

Current Issue Highlights

A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares

McCall, William Vaughn; Pillai, Anilkumar; Case, Doug; More

Journal of Clinical Psychopharmacology. 38(6):618-621, December 2018.